Navigation Links
Isodiol International Inc. Receives Regulatory (ANVISA) Approval for Isoderm for the Treatment of Epilepsy and Parkinson's
Date:7/7/2017

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has received approval from the Brazilian Health Regulatory Agency (ANVISA) for the approval of its pharmaceutical grade Cannabidiol (CBD) product, Isoderm™. This product will be placed on the Special Category List for alternative therapies which will enable it to be prescribed by doctors and neurologists.

Isodiol International CEO Marcos Agramont stated, “We had initially anticipated this process to lead us into the third quarter, however receiving the first approval in a few months shows the quality and market demand for our Isoderm™ product. We anticipate additional product and medical indication approvals to continue over the coming weeks and months. We will strengthen our distribution relationships in the region and continue working towards receiving product approvals in other jurisdictions. We will continue to be proactive and mitigate the regulatory risk in North America by increasing our footprint in countries that have approved medical CBD. By increasing our global presence, we feel we will be in a position to influence the regulatory and legal framework of this movement into a sustainable industry domestically in Canada and the US.”

Additional information will be provided in the coming weeks around the progress of distribution partnerships.

ON BEHALF OF THE BOARD

“Marcos Agramont” CEO & Director

COMPANY MEDIA:

Isodiol.com
CBDnaturals.com
Iso-sport.com
CBDskincream.com
Potocoffee.coffee

ir(at)isodiol(dot)com
Join Us On Facebook: https://www.facebook.com/Isodiol/
Twitter: @isodiol

Forward-Looking Information:

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.

Read the full story at http://www.prweb.com/releases/2017/07/prweb14486350.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Isodiol Launches No THC, CBD-Only Cannabis Infused Water, Edibles and Cosmetics at National Marijuana Business Conference
2. Georgia State Hosts First International Triple Negative Breast Cancer Conference
3. Caduceus International Publishes a New Accredited Personal & Community Health Online Course For 2017
4. Fenway Health's Dr. Kenneth Mayer Appointed New Editor-In-Chief Of the Journal of the International AIDS Society
5. Clarion Safety Systems Shares Update On Standardization Of Symbols Following International Standards Meetings
6. NSF International Standard to Address Legionnaires’ Disease Risks Described by U.S. CDC
7. Clearwave to Exhibit at the 2017 International Muse Conference in Dallas
8. Lexli International Launches Skin Care Affiliate Program
9. Lillibridge Healthcare Services Playing Major Roles At BOMA International’s 2017 Medical Office Buildings + Healthcare Real Estate Conference In Denver
10. DKT International Releases 2016 Impact Data Marking their Best Year Yet for Family Planning and HIV Prevention
11. Hundreds of Experts Attend European International Kidney Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2019)... JOSE, Calif. (PRWEB) , ... January 19, 2019 ... ... and management, Dr. Nakahira is responsible for ensuring the availability, quality and delivery ... activities of Utilization Management, Case Management, Quality Improvement, Pharmacy, Long-Term Services and Supports ...
(Date:1/14/2019)... ... January 14, 2019 , ... After many months of ... new clinic in Phoenix, Arcadia Allergy & Asthma. This new allergy and asthma clinic ... it a great one stop destination for any immunological and respiratory medical care needs. ...
(Date:1/14/2019)... ... , ... Jeffery Nelson, M.D., FACS, FASCRS , Surgical ... Digestive Health & Liver Disease at Mercy Medical Center , now offers patients ... as a suction hemorrhoid ligator is used with the procedure; this device holds ...
(Date:1/14/2019)... Columbia (PRWEB) , ... January 14, 2019 , ... ... announce the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS ... IAPC EHS audit protocols to understand the scope of their EHS regulatory obligations ...
(Date:1/11/2019)... BURLESON, Texas (PRWEB) , ... January 11, 2019 , ... ... will provide free dental services for low-income, underinsured individuals at its Burleson, TX ... exams and x-rays, fillings, cleanings and extractions . For ...
Breaking Medicine News(10 mins):
(Date:1/8/2019)... ... January 08, 2019 , ... ... as a UroLift® Center of Excellence. The designation recognizes that Dr. Jaeger has ... demonstrated a commitment to exemplary care for men suffering from symptoms associated with ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... as a kind of partnership. The implicit terms of this partnership hold that ... and administer the most effective treatment to restore the patient to improved health. ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... United States every 4 ½ minutes. We can change that alarming statistic,” said ... Organization of Teratology Information Specialists (OTIS). MotherToBaby is joining with leading prenatal health ...
Breaking Medicine Technology: